Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

New AQUIOS CL Clinical Cytometer* For Routine Applications in Clinical Lab

Published: Tuesday, June 10, 2014
Last Updated: Wednesday, June 11, 2014
Bookmark and Share
The fully automated instrument delivers fast, efficient results.

Beckman Coulter Life Sciences is set to transform the use of flow cytometry in the routine clinical laboratory with its latest offering, the Aquios CL Clinical Flow Cytometer*. Fully automated, with a small footprint, the instrument is the first authentic ‘LOAD & GO’ cytometry system.

The Aquios CL is designed specifically to streamline workflow and reduce backlogs when handling routine applications, such as immunophenotyping. The Aquios CL delivers first results within 20 minutes, with subsequent results at a rate of 25 samples per hour for up to a full 96-well plate.  

As easy to learn and use as a haematology analyser, it can be operated with minimal training, freeing up resources for more complex assay analysis.  By removing manual processes, the high level of automation helps prevent sample processing errors.  Its cap-piercing technology reduces staff exposure to biohazardous samples.

This fully integrated system includes a 40-tube capacity autoloader able to handle a variety of tube sizes, with continuous, random loading and unloading.  There is a separate single-tube loader for STAT samples.  Sample preparation, reagent monitoring, barcode scanning, data analysis and LIS connectivity are all automated.  

* Pending submission and clearance by the United States Food and Drug Administration; not yet available for in vitro diagnostic use. The device has not yet been licensed in accordance with Canadian law. The performance specifications of this product have not been established.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Beckman Coulter Diagnostics Obtains CE Marks for DxN VERIS HCV Assay
Growing menu of assays allow for rapid turnaround of results with a more efficient workflow.
Thursday, June 11, 2015
FDA Clears Beckman's AQUIOS CL Flow Cytometer For Clinical Labs
The company's new, automated AQUIOS CL Flow Cytometer has received clearance from the U.S. Food and Drug Administration (FDA) for routine applications in the clinical laboratory.
Wednesday, May 06, 2015
Beckman Coulter Diagnostics and Seegene Supply Agreement
Supply agreement announced for multiplex reagents for VERIS molecular diagnostics system.
Monday, November 17, 2014
Beckman Coulter Obtains CE Mark for VERIS MDx System
Beckman Coulter Diagnostics has obtained CE Mark for the VERIS MDx System* and VERIS human Cytomegalovirus (CMV) assay*.
Monday, May 12, 2014
Beckman To Acquire Cytometer Developer Xitogen
Acquisition will broaden product offering, providing an Asian operations centre.
Wednesday, April 23, 2014
New Beckman Coulter Assay Receives FDA Clearance and CE Mark
Assay is first to standardize to World Health Organization’s 5th International Standard for chorionic gonadotropin.
Friday, January 17, 2014
Scientific News
Autism and Cancer Share a Remarkable Number of Risk Genes
Researchers with the UC Davis Comprehensive Cancer Center, MIND Institute identify more than 40 common genes.
Number Of Known Genetic Risk Factors For Endometrial Cancer Doubled
An international collaboration of researchers has identified five new gene regions that increase a woman’s risk of developing endometrial cancer, one of the most common cancers to affect women, taking the number of known gene regions associated with the disease to nine.
Five New Breast Cancer Genes Found
Discovery of mutations paves the way for personalised treatment of breast cancer.
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Magnetic Nanoparticles May Reveal Early Traces Of Cancer
Rice University students’ computer program aids MD Anderson diagnostic initiative .
New Blood Test for The Earlier Diagnosis of Breast Cancer Spread
Researchers at University of Westminster have confirmed that a new blood test can detect if breast cancer has spread to other parts of the body.
Genetic Approach May Lead to New Treatments for Digestive Diseases
Researchers at UMass Medical School have identified a new molecular pathway critical for maintaining the smooth muscle tone that allows the passage of materials through the digestive system.
Biomarkers for Profiling Prostate Cancer Patients
Exiqon A/S has announced the publication of validation of prognostic microRNA biomarkers for the aggressiveness of prostate cancer in independent cohorts.
World-First Blood Test For Parkinson's
La Trobe University researchers have developed a world-first diagnostic blood test which could change the lives of people with Parkinson's disease.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!